Tuesday, November 10, 2020

Glenmark Pharma Gets Nod For Tacrolimus Capsules; Stock Gains Nearly 2%

Glenmark Pharma received final approval from USFDA for Tacrolimus capsules, which are used as immunosuppressants to prevent human immune system from rejecting liver, kidney and heart transplants.

from NDTV Profit - Latest https://ift.tt/3lkCdcp

No comments:

Post a Comment